Importance of muscle biopsy to establish pathogenicity of DMD missense and splice variants
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 29 (12) , 913-919
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
This publication has 26 references indexed in Scilit:
- The importance of genetic diagnosis for Duchenne muscular dystrophyJournal of Medical Genetics, 2016
- DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype CorrelationsPLOS ONE, 2015
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy MutationsHuman Mutation, 2015
- New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapyJournal of Human Genetics, 2014
- The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practiceNeuromuscular Disorders, 2013
- Missense mutations in dystrophin that trigger muscular dystrophy decrease protein stability and lead to cross-β aggregatesProceedings of the National Academy of Sciences, 2010
- Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregationProceedings of the National Academy of Sciences, 2010
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohortHuman Mutation, 2009
- Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebaseHuman Mutation, 2009
- Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophyJournal of Medical Genetics, 2007